Cargando…
Evaluating variation in use of definitive therapy and risk-adjusted prostate cancer mortality in England and the USA
OBJECTIVES: Prostate cancer mortality (PCM) in the USA is among the lowest in the world, whereas PCM in England is among the highest in Europe. This paper aims to assess the association of variation in use of definitive therapy on risk-adjusted PCM in England as compared with the USA. DESIGN: Observ...
Autores principales: | Sachdeva, Ashwin, van der Meulen, Jan H, Emberton, Mark, Cathcart, Paul J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342590/ https://www.ncbi.nlm.nih.gov/pubmed/25712821 http://dx.doi.org/10.1136/bmjopen-2014-006805 |
Ejemplares similares
-
Detailing sexual outcomes after treatment of localised prostate cancer with focal therapy using various energy sources: protocol for a mixed-methods study
por: Fiard, Gaelle, et al.
Publicado: (2020) -
Assessment of a patient-reported outcome measure in men with prostate cancer who had radical surgery: a Rasch analysis
por: Protopapa, Eva, et al.
Publicado: (2020) -
Prostate-specific membrane antigen positron emission tomography compared to multiparametric MRI for prostate cancer diagnosis: a protocol for a systematic review and meta-analysis
por: Zhao, Yi, et al.
Publicado: (2021) -
Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysis
por: Norris, Joseph M, et al.
Publicado: (2020) -
Relationship of prostate cancer topography and tumour conspicuity on multiparametric magnetic resonance imaging: a protocol for a systematic review and meta-analysis
por: Satish, Pranav, et al.
Publicado: (2022)